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Abstract: Traumatic brain injury (TBI) commonly results in primary diffuse axonal injury (DAI) and
associated secondary injuries that evolve through a cascade of pathological mechanisms. We aim
at assessing how myelin and oligodendrocytes react to head angular-acceleration-induced TBI in a
previously described model. This model induces axonal injuries visible by amyloid precursor protein
(APP) expression, predominantly in the corpus callosum and its borders. Brain tissue from a total
of 27 adult rats was collected at 24 h, 72 h and 7 d post-injury. Coronal sections were prepared for
immunohistochemistry and RNAscope® to investigate DAI and myelin changes (APP, MBP, Rip),
oligodendrocyte lineage cell loss (Olig2), oligodendrocyte progenitor cells (OPCs) (NG2, PDGFRa)
and neuronal stress (HSP70, ATF3). Oligodendrocytes and OPCs numbers (expressed as percentage
of positive cells out of total number of cells) were measured in areas with high APP expression.
Results showed non-statistically significant trends with a decrease in oligodendrocyte lineage cells
and an increase in OPCs. Levels of myelination were mostly unaltered, although Rip expression
differed significantly between sham and injured animals in the frontal brain. Neuronal stress markers
were induced at the dorsal cortex and habenular nuclei. We conclude that rotational injury induces
DAI and neuronal stress in specific areas. We noticed indications of oligodendrocyte death and
regeneration without statistically significant changes at the timepoints measured, despite indications
of axonal injuries and neuronal stress. This might suggest that oligodendrocytes are robust enough
to withstand this kind of trauma, knowledge important for the understanding of thresholds for cell
injury and post-traumatic recovery potential.
Keywords: diffuse axonal injury; traumatic brain injury; myelin degradation; oligodendrocyte progenitor
cell; olig2
1. Introduction
Traumatic brain injury (TBI) is an important public health problem and is the leading cause
of disability and death among young adults [1,2]. A thorough understanding of the pathological
mechanisms behind TBI, such as myelin and oligodendrocyte loss and regeneration, and the time
window in which such mechanisms might occur, sets the basis for developing timely therapeutic
approaches that might aid in recovering tissue damage and in restoring function.
When the head is exposed to rotational accelerations, common in sports-related accidents and in
road traffic accidents, the brain lags behind in a non-homogeneous way [3,4], producing shearing and
strain of the brain tissues. Shearing and strain is especially seen at the borders between tissues with
Brain Sci. 2020, 10, 229; doi:10.3390/brainsci10040229 www.mdpi.com/journal/brainsci
Brain Sci. 2020, 10, 229 2 of 27
different stiffness properties, e.g., the border between the corpus callosum and cortex, where large
concentrations of injured cells are found [5].
Rotational accelerations of the head, here referred to as rotational TBI, may lead to tissue loadings
that could produce primary axotomy. [6,7] While this type of axotomy might occur during severe
trauma, it is far more common that axotomy evolves over time after the trauma (secondary axotomy),
with the axons undergoing Wallerian degeneration [7–9]. At the time of injury, axons may be stretched
and undergo cytoskeletal damage due to neurofilament compaction and mechanoporation of the cell
membrane, which results in membrane leakage, ionic disturbances, and osmotic imbalance [5,10].
Cytoskeletal damage results in impaired axoplasmic transport and proteins such APP and NF
accumulate, leading to the formation of axonal bulbs [11]. APP thus serves as a useful marker
for investigating axonal injury [12,13]. In the days to weeks following injury, such progressive
disorganization of the axonal cytoskeleton and protein accumulation leads to secondary axotomy [5,7,11].
Other than axonal injury, these events are thought to be related to oligodendrocyte apoptosis, neuronal
somata perturbations and death [14,15]. Heat shock proteins such as HSP70 and Activating Transcription
Factor 3 (ATF3) are induced following stress of different nature (e.g., trauma, ischemia, hyperthermia
and hypoxia) [16,17] and have been found to be upregulated early following TBI in humans and in
animals, hence forming useful markers to detect areas of cell stress following trauma [14,18,19].
Axonal injury is thought to cause myelin damage by direct structural damage to the adjacent
myelin membrane when the axon undergoes primary axotomy, often initiating at the nodes of the
Ranvier and para-nodal region [20]. Alternatively, myelin can be damaged indirectly following the
release of glutamate and other excitatory amino acids from neurons that have been mechanically
disrupted following trauma, resulting in calpain-mediated Myelin Basic Protein (MBP) degradation.
MBP is a major structural protein of the myelin sheath and its degradation—which is seen as early
as 48 h—might lead to myelin sheath instability and demyelination [21–23]. Moreover, MBP mRNA
expression was shown to be decreased following shear stress in the context of the direct mechanical
stimulation of Schwann cells [24].
Myelin degradation is not only a consequence of axonal injury; the demyelination of non-injured axons
might occur following TBI, when TBI induces a loss of oligodendrocytes [20,25], since oligodendrocytes
function in producing and maintaining the myelin sheaths. Oligodendrocytes are lost as they undergo
apoptosis, which is triggered by excitotoxicity, oxidative stress, and caspase-3-mediated cell death
mechanisms. These events have been widely described occurring following TBI [26–28], resulting from
glutamate release from internal stores in the neuron cell body, calcium overload and mechanoporation.
The loss of oligodendrocytes leads to myelin sheath collapse and degradation, eventually leading to axon
demyelination. Demyelinated axons are prone to damage, so the loss of oligodendrocytes might also lead
to secondary axonal injury [29–32].
As oligodendrocyte loss following TBI takes place, immunostaining with markers specific for
oligodendrocytes, such as anti-Olig2, might reveal a decreased number of such cells [33,34]. Olig2 is a
basic helix–loop–helix transcription factor restricted to the oligodendrocyte lineage. It is expressed
throughout the life of the oligodendrocyte, from its early development to maturity [35], hence anti-
Olig2 is a good marker to evaluate the oligodendrocyte population.
Oligodendrocyte death and demyelination are known to be major triggers for oligodendrocyte
progenitor cells’ (OPCs) activation and proliferation [36]. OPCs are adult resident progenitor cells
present throughout the adult brain with the potential to proliferate and differentiate given the right
stimuli. Activated OPCs slowly migrate to the site of injury, where they differentiate into mature
myelin-producing oligodendrocytes. For this to occur, OPCs must switch from resting to active
state, which shows enlarged cell bodies and hypertrophied processes. Then, OPCs will attempt to
re- myelinate axons and heal the damage [37,38]. Re-myelination is defined as the process by which
damaged myelin sheath is replaced by newly formed myelin [38–41]. Moreover, other than from OPCs,
oligodendrocytes develop from stem cells in the subventricular zone [42,43].
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Thus, if in the first moments following injury it might be possible to observe a decreased number
of Olig2+ cells secondary to mature oligodendrocyte death, it is likely that then—as the process of
OPCs’ activation and proliferation takes place—overall Olig2+ cells might increase in number [33,34].
To differentiate Olig2+ oligodendrocytes from Olig2+ OPCs, markers specific to OPCs can be used,
such as anti-NG2. The NG2 is a chondroitin sulfate proteoglycan present on the plasma membrane of
OPCs. NG2+ cells have been shown to increase in number following spinal cord injury and TBI [44,45].
Given the role that OPC proliferation has in re-myelination, and the clinical importance of myelination
in terms of signal conduction and axonal integrity, additional knowledge of the rate and magnitude of
myelin degeneration, oligodendrocyte loss and oligodendrocyte reactive proliferation, may contribute to
the improved diagnosis and treatment of TBI. From this perspective, we aim at assessing how the myelin
and cells involved in its formation and degradation—oligodendrocytes—react to TBI induced by angular
acceleration of the head of rats.
2. Materials and Methods
2.1. Animal Preparation
The experiments were carried out on 27 male Sprague-Dawley rats (weighing 440.8 ± 102.3 g),
divided into exposed groups and sham and exposed to different survival times (24 h, 72 h, 7 d). Of the
27 rats, 18 (weighing 425.2 g ± 45.3 g) were included in both the quantitative and qualitative analysis,
equally divided among sham and exposed groups (Table 1). All the animals were deeply anesthetized
by 2.4 mL/kg intra-abdominal injections of a mixture of Fentanyl, Midazolam and Domitor. Thereafter,
the subjects were given 0.2 mL/kg intra-muscular injections every 30 min until pre-surgery, trauma and
post-surgery were carried out.
Table 1. Information on the animals included in the study. The table summarizes information about the
trauma, angular acceleration, survival time and weight of the animals included in the study. (A) refers to
subjects who were included in both quantitative and qualitative analysis, while subjects in (B) were
included only in preliminary qualitative assessments.
A
Subjects Trauma Level Survival Time Weight ± SD (g)
18 Sprague-Dawley rats
Sham→ n = 9
24 h→ n = 3 411.7 ± 17.9
72 h→ n = 3 429.7 ± 12.7
7 d→ n = 3 399.7 ± 18.6
0.96–1.34 Mrad/s2 → n = 7
24 h→ n = 3 444.7 ± 16.2
72 h→ n = 3 478 ± 88.7
7 d→ n = 1 376
1.35–2.18 Mrad/s2 → n = 2 7 d→ n = 2 393.5 ± 23.3
B
Subjects Trauma Level Survival Time Weight ± SD (g)
9 Sprague-Dawley rats
Sham→ n = 2
24h→ n = 1 372
72h→ n = 1 354
0.96–1.34 Mrad/s2 → n = 1 72h→ n = 1 749
1.35–2.18 Mrad/s2 → n = 6
24h→ n = 3 364.7 ± 9.0
72h→ n = 3 559.3 ± 181.4
All the work performed was in accordance with the Swedish National Guidelines for
Animal Experiments and approved by the Stockholm Animal Care and Use Ethics Committee
(Stockholm, Norra Djurfösöksetiska Nämnd). Ethical permit numbers: NG22/10, N248/11, N81/13.
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2.2. Experimental Setup
The rotational TBI was produced using a model described by Davidsson and Risling [46].
This model allows for sagittal plane rotational acceleration of the head of rats (Figure 1) and simulates
forehead to hard structure impacts. The model allows to assess graded levels of inertia-induced brain
injuries without major contusion.
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investigations on the same model of injury, which show a linear increase in APP expression from 
values of 1 Mrad/s2 [46]. After trauma, the attachment plate was removed, the skin was made to cover 
the skull cap, and eight to ten sutures closed the incision.  
The animals were kept under standard animal care conditions for survival times of 24 h (n = 6 
for traumatized and n = 4 for sham), 72 h (n = 7 for traumatized and n = 4 for sham) and 7 d (n = 3 for 
traumatized and n = 3 for sham). 
2.3. Dissection and Immunohistochemistry 
The brains were removed and split into several units and fresh frozen on dry ice. In this study, 
a minimum of nine coronal cryostat sections were cut from a unit at 1.5–0.5 mm relative to bregma 
(referred to as frontal sections), from a unit at −3.0 to −6.0 mm relative to the bregma (referred to as 
occipital sections). The sections were put onto slides and allowed to airdry for 30–60 min at room 
temperature (20 °C). The slides where fixed in 4% buffered formalin for 10 min and subsequently 
rinsed in 0.01 M PBS twice for 10 min. The sections were incubated overnight in a humid chamber at 
4 °C with one or more primary antibodies. All primary antibodies (Table 2) were diluted in 0.01 M 
PBS containing 5% donkey serum, 5% bovine serum albumin, 0.3% triton. The sections were then 
soaked in 0.01 M PBS twice for 10 min and incubated for 40 min at room temperature with the 
secondary antibodies (Cy3 donkey anti-mouse; Dy488 donkey anti-rabbit; Cy2 donkey anti-goat). All 
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the bone. A skull cap was glued to the bone and an attachment plat was fastened by means of w
screws o the skull cap. Then, the attachment plate was inserted and secured to rota ing bar that can
rotate freely ar und its horizontal axis. The resulting center of rotation was locat 1 mm below the
head base and 5 mm nterior to the fr of the foram n magnum. Both sh m and trauma-exposed
groups und rwent these procedur s.
During trauma, a striker was accelerat d in a specially designed air-driven accelerator and was
made to hit a r bber block att ched to striker target attached to the rotating bar. The impulse
pro uced subjected the r tating bar and the animal head to s ort sagittal pl ne rearward rotational
acceleration. Th rotati n l acceleration m gnitude was selected by modifying the striker speed,
which was varied by mea s of modifying air press re in the acc lerator. The acceleration elected in this
study ranged b tween 0.96–2.2 Mrad/s2 while th d rat ons of the accele ations w r identical (0.4 ms).
Such an angular acc leration range was selected based on esults from previous inve tigations on the
same model of injury, which show a linear increase in APP expression fr m val es of 1 Mrad/s2 [46].
Aft r trauma, the attach nt plate was removed, t e skin was made to cover the skull cap, and eight
to ten sutures clo ed the incision.
The animals were kep under standard animal are conditions for survival times of 24 h (n = 6 for
traumatized and n = 4 for sham), 72 h (n = 7 for traumatized and n = 4 fo sh m) and 7 d (n = 3 for
traumatized and = 3 for sham).
2.3. Dissection and Immunohistochemistry
The brains were removed and split into several units and fresh frozen on dry ice. In this study,
a minimum of nine coronal cryostat sections were c t from a unit at 1.5–0.5 mm relative to bregma
(referred to as frontal sections), from a unit at −3.0 to −6.0 mm relative to the bregm (r ferred to as
occipital sections). The sections were put onto slides and allowed to airdry for 30–60 min at r om
tem erature (20 ◦C). Th slides h re fixed in 4% buffered formalin for 10 min and subsequently
rinsed in 0.01 M PBS twice for 10 min. The sections were incubated overnight in a humid chamber at
4 ◦C with one or more primary antibodies. All primary antibodies (Tabl 2) were diluted in 0.01 M PBS
containing 5% donkey serum, 5% bovine erum albumin, 0.3% triton. Th sections were the soaked
in 0.01 M PBS twice for 10 min and incubated for 40 min at room temperatur with the secondary
antibodies (Cy3 donkey anti-m use; Dy488 donkey anti-rabbit; Cy2 donkey anti-goat). All secondary
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antibodies were diluted in 0.01 M PBS containing 0.3% triton. All slides were incubated for five minutes
with DAPI stain (1 µL DAPI stock solution in 4 mL 0.01 M PBS) to visualize cell nuclei and served as a
background anatomical map, and were then soaked in 0.01 M PBS twice for 10 min. Finally, the slides
were mounted in Mowiol 4-88 (Polyscience) and cover slipped.
Table 2. List of primary antibodies used in the study.
Antibody Dilution Supplier, Catalogue Number
Amyloid precursor protein (APP) 1:200 Invitrogen, 51-2700
Myelin Basic Protein (MBP) 1:200 Merk Millipore, Ne1019
Rip 1:300 DSHB
Olig2 1:500 AbCam, Ab109186
NG2 1:200 Millipore, A25320
Occludin 1:100 Santa Cruz, Sc-8145
A2B5 (4D4 A2B2-like-supernatant) 1:50 DSHB
HSP70 1:200 Santa Cruz, Sc-66048
ATF3 1:100 Santa Cruz, Sc-81189
Primary antibodies were used or combined in the following ways: anti-APP antibody was used to
detect axonal injuries, anti-MBP antibody and anti-Rip antibody were used to detect myelin changes,
anti-Olig2 antibody was used to detect the presence of oligodendrocyte lineage cells. The anti-MBP
antibody was combined either with anti-Olig2 or anti-APP antibody to assess the myelination status in
conjunction with oligodendrocyte losses or with the degree of axonal injury. An anti-NG2 antibody,
a chondroitin sulphate antibody, was used to detect OPCs, and it was combined with anti-Occludin-1
antibody to differentiate OPCs from blood vessels. An anti-A2B5 antibody was used to detect immature
glial precursor cells, and thus to detect early differentiating OPCs. Anti-HSP70 and anti-ATf3 were
used to detect neuronal somata stress, in combination with anti-APP.
2.4. RNAscope® ISH
In situ hybridization was performed on fresh frozen sections, as directed by the manufacturer
(Advanced Cell Diagnostics, Hayward, CA, USA) [47]. Custom RNAscope® target-specific
oligonucleotide (ZZ) probes were designed by Advanced Cell Diagnostics (Advanced Cell Diagnostics,
Newark, CA, USA) targeting nucleotides 375-1986 (NM_001100557.1) for Olig2 and 1516-2531
(NM_012802.1) for PDGFRa of Rattus Norvegicus (Table 3). Slides were counterstained with cresyl
violet, mounted in Mowiol 4-88 (Polyscience) and cover slipped. The rn-PPIB gene targeting nucleotides
95-830 (NM_022536.2) was used as positive control probe.
Table 3. List of RNAscope® probes.
Target mRNA Probe Nucleotides Accession Number
Olig2 375-1986 NM_001100557.1
PDGFRa 1516-2531 NM_012802.1
2.5. Microscopic and Statistical Analyses
Immunohistochemistry (IHC) sections were examined using a Nikon Ni-Eclipse microscope with
Andora Zyla fluorescence camera and Nikon DS-Fi2 light camera, and Nikon Eclipse E600 confocal
microscope. Regions of interest were defined based on evidence of injuries from previous TBI studies
using the rotational model adopted in this study. For frontal sections, analysis focused on the corpus
callosum (just dorsal of the lateral ventricles—in this study referred to as CC “SVZ”—and ventral
of the cingulum and dorsal of the interface with the caudoputamen—in this study referred as CC
“border”) and dorsal cortex (Figure 2A). For occipital sections, analysis focused on the corpus callosum,
dorsal cortex and habenular nuclei (Figure 2B).
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A thorough histol ic l e i ti t ra hic documentation was done in order to
perform a lit ti analysis of the adopted rotational brai injury model. During microscopy,
the obs ver localized the region of interest and d scribed at 10× magnification the gross pattern
of each antibody expression, i.e., whether it was expressed or not, and if its expr ssion clustered
in specific areas. Tw to three overview photographs per side—depending on the extension of the
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APP expression as analyzed by anually counting the PP axon terminals in each ROI bilaterally.
RNAscope slides ere examined using Nikon Ni-Eclipse microscope with light camera.
All images used to quantify Olig2+ and PDGFRa+ cell numbers were taken at 20× magnification
with unifor camera settings. For these images, a quantitative analysis was performed using the
software Fiji ImageJ (Wayne Rasband, NIH http://imagej.nih.gov/ij) following the guidelines suggested
by Advance Cell Diagnostics for slides processed with RNAscope® [48]. The parameters used for
interpreting the results and statistical analysis were the percentage of positive cells in the region of
interest (ROI).
The observer had experience in microanatomy, was aware of the regions to be documented and
the antibody of use, but was blinded to the treatment and time point being analyzed.
For each of the quantitative analyses, a two-tail unpaired t-test (GraphPad Prism software) was
performed to establish differences between the sham and exposed groups, while one-way ANOVA
test was used for establishing differences between the exposed groups at different survival times.
Statistical significance was assumed for p values ≤ 0.05. All the results are presented as average
values ± standard deviation.
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3. Results
3.1. Axonal Injury: Anti-APP Antibody
Intense APP staining was observed in rotational TBI-exposed subjects as opposed to shams,
which did not express any APP, frontally in the corpus callosum close to the borders with both the
cortex, caudoputamen and the lateral ventricles (Figure 3). However, in the occipital portion of the
corpus callosum (around −3 mm from Bregma), APP-positive bulbs appeared to be more scarcely
distributed (p ≤ 0.05) than in the frontal corpus callosum (about 1.3 mm from Bregma) (Figure 3K–M).
Otherwise, throughout the corpus callosum, APP-positive profiles appeared scattered and smaller in
size than at its borders. APP+ profiles appeared more abundant at 24 h and 72 h than at 7 d (p ≤ 0.05)
(Figure 3K–M).
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APP expression is maximal at 24 h and decreases thereafter, with p ≤ 0.05 at one-way ANOVA
analysis. Scale bar = 300 µm (top row); scale bar = 500 µm (bottom row); scale bar = 150 µm (C insert);
scale bar = 500 µm (E insert).
3.2. Oligodendrocyte Lineage Cells: Anti-Olig2 Antibody and Olig2 mRNA
Oligode drocyte population was studied through anti-Olig2 antibody. In e corpus callosum,
both in the frontal and in the occipital sections, Olig2 was expressed at baseline levels, with no clear
differences seen between sham and injured animals by visual inspection (Figure 4). In order to have
a detailed understanding of the changes in oligodendrocyte lineage cell densities following injury,
the percentage of cells expressing Olig2 mRNA was estimated in regions of interest (corpus callosum
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dorsal of the lateral ventricles, at its border with the caudoputamen and occipitally just lateral of the
midline) from light microscopy pictures of RNAscope® slides. By visual inspection, a difference in
amount of mRNA being expressed could be observed, with more abundant and larger mRNA clusters
in sham animals at longer survival times. These changes were not statistically significant, although the
analysis provided that there appears to be a trend of higher percentage of Olig2 mRNA-expressing cells
in sham as compared to injured animals and a decrease in the percentage of positive cells in injured
rats at 7 d as compared to 24 h when considering only the smaller ROI at the border of the corpus
callosum and caudoputamen. (Figure 5).
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found in the corpus callosum regions of interest. The difference between injured and sham animals 
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cells expressing PDGFRa mRNA (out of all of the cells counterstained by cresyl violet) were counted 
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Figure 5. RNAscope analysis with Olig2 mRNA probe of corpus callosum. (A,C,E) Sample of RNAscope
light microscopy picture of njured subjects set for analysis with Fiji ImageJ. The insert shows the
region of interest squared in red, namely (A) CC just dorsal of the subventricular zone (CC “SVZ”),
(C) area of the corpus callosum at around 1 mm from Bregma at the border with the caudoputamen,
and (E) corpus callosum at around −3 mm from Bregma. All the cells considered for the analysis are
circled in green, while in red are the Olig2 probe clusters. In yellow is what has been manually excluded
because it was considered as background/not part of the region of interest. (B,D,F) Results from the
image analysis are presented as averages of the percentages of the number of cells expressing Olig2
mRNA out of the total number of cells from each subject in the ROI. While a trend with a lower number
of Olig2 was observed in injured as compared to sham, such a difference was not statistically significant
at any timepoint. * p indicates results from one-way ANOVA analysis, while p is from Student t-test.
3.3. ligodendrocyte Progenitor Cells: Anti-NG2, Anti-A2B5 Antibodies and PDGFRa mRNA
OPCs were labelled using anti-NG2 antibody and immature glial precursor cells (so to detect early
differentiating OPCs) using ti-A2B5 ant body. Analysis of the brain sections f rotational TBI subjects
revealed that A2B5+ cells localized predominantly at the subventricular zone, apparently decreasing
at 7 d as compared to 24 h (Figure 6).
Brain Sci. 2020, 10, 229 10 of 27
To identify OPCs, slides were co-labelled with anti-NG2 antibody and anti-Occludin antibody
(specific for the vessel’s tight junctions) so as to distinguish NG2+ OPCs from NG2+ vessel walls.
Visual analysis was performed at fluorescence and confocal microscopes. Scattered NG2+ OPCs were
found in the corpus callosum regions of interest. The difference between injured and sham animals
could not be readily identified (Figures 7 and 8). For the quantitative analysis of OPCs, percentage of
cells expressing PDGFRa mRNA (out of all of the cells counterstained by cresyl violet) were counted at
all timepoints and regions of interest (Figure 9). Results were compared by means of two-tail unpaired
t-test between sham and injured animals, and by means of one-way ANOVA test between injured
animals at different timepoints. Statistical analysis revealed decreased percentage of cells expressing
PDGFRa mRNA both by 7 d (7 d < 24 h) and in the injured animals as compared to shams in the frontal
brain sections. In more occipital sections (around −3 mm from bregma), instead, higher percentages of
PDGFRa mRNA-expressing cells were recorded in injured rats than in shams. However, none of these
trends showed statistical significance.
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Figure 6. A2B5 expression in the subventricular zone. (insert) The highlighted area refers to the regions
of interest represented in the microscopy pictures. (A–D) Abundant A2B5 positivity can be seen in the
subventricular zone, but is apparently decreased at 7 d. Scale bar = 200 µm.
Brain Sci. 2020, 10, 229 11 of 27Brain Sci. 2020, 10, x FOR PEER REVIEW 11 of 26 
 
Figure 7. NG2 expression in the corpus callosum at around 1 mm from bregma. (A–D) Fluorescence 
microscopy photographs show NG2+ oligodendrocyte progenitor cells in the corpus callosum. 
Double staining with Occludin (red) was done to distinguish NG2+ (green) vessel walls from 
oligodendrocyte progenitor cells (OPCs). DAPI+ nuclei are stained in blue. Arrows show 
NG2+/DAPI+/Occludin− OPCs, which appear scattered throughout the corpus callosum, with no 
apparent difference between sham and trauma-exposed subjects. Insert: the highlighted area refers to 
the area represented in A-D. Scale bar = 50 μm. 
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Figure 7. NG2 expression in the corpus callosum at around 1 mm from bregma. (A–D) Fluorescence
microscopy photographs show NG2+ oligodendrocyte progenitor cells in the corpus callosum.
Double staining with Occludin (red) was o e t distinguish NG2+ (green) vessel walls from
oligodendrocyte progenitor cells (OPCs). DAPI+ nuclei are stained in blue. Arrows show
NG2+/DAPI+/Occludin− OPCs, which appear scattered throughout the corpus callosum, with no
apparent difference between sham and trauma-exposed subjects. Insert: the highlighted area refers to the
area represented in (A–D). Scale bar = 50 µm.
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Double staining with Occludin-1 (red) was done to distinguish NG2+ (green) vessel walls from OPCs. 
Arrows indicate OPCs as shown by the expression of NG2 on the XYZ planes. NG2+ OPCs are 
scattered throughout the corpus callosum, with no apparent difference between sham and trauma-
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Figure 8. NG2 expression in the corpus callosum at around -3 mm from bregma. (A–D) Confocal
microscopy photographs show NG2+ oligodendrocyte progenitor cells in the corpus callosum.
D uble staining with Occludin-1 (red) was done to istinguish NG2+ (g een) vessel walls from OPCs.
Arrows indicate OPCs as shown by the expression of NG2 o the XYZ planes. NG2+ OPCs are scattered
throughout the corpus callosum, with no apparent difference between sham and trauma-exposed
subjects. Insert: the highlighted area refers to the area represented in (A–D). Scale bar = 20 µm.
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shows the region of interest squared in red, namely (A) CC just dorsal of the subventricular zone (CC 
“SVZ”), (C) area of the corpus callosum at around 1 mm from Bregma at the border with the 
caudoputamen, and (E) corpus callosum at around −3 mm from Bregma. All the cells considered for 
the analysis are circled in green, while in red are the PDGFRa probe clusters. In yellow is what has 
been manually excluded because it was considered as background/not part of the region of interest. 
(B,D,F) Results from the image analysis are presented as averages of the percentages of the number 
of cells expressing PDGFRa mRNA out of the total number of cells from each subject in the ROI. While 
a trend of an increased number of PDGFRa-expressing cells was observed in injured as compared to 
sham when analyzing the whole width of the corpus callosum at around 1 and −3 mm from bregma, 
this is not true when considering a smaller ROI of the corpus callosum at around 1 mm from bregma. 
Moreover, such differences were at no timepoint statistically significant. *p indicates results from one-
way ANOVA analysis, while p is from Student t-test. 
3.4. Myelin Pathology: Anti-MBP and Anti-Rip Antibodies 
Myelin changes following rotational TBI were investigated by means of anti-MBP antibody, 
which recognizes the 21.5 kDa MBP isoform, and the anti-Rip antibody, which recognizes the 2,3 
cyclic nucleotide 3-phosphodiesterase in mature, myelinating oligodendrocytes and myelin sheaths.  
Figure 9. RNAscope analysis with PDGFRa mRNA probe of corpus callosum. (A,C,E) Sample of
RNAscope light microscopy picture of injured subjects set for analysis with Fiji ImageJ. The insert
shows the region of interest squared in red, namely (A) CC just dorsal of the subventricular zone
(CC “SVZ”), (C) area of the corpus callosum at around 1 mm from Bregma at the border with the
caudoputamen, a d (E) corpus callosum at round −3 mm from Bregma. All the cells considered for
the analysis are circled in green, while in red are the PDGFRa probe clusters. In yellow is what has
been anually excluded because it was considered as background/not part of the region of interest.
(B,D,F) Results from the image analysis are presented as averages of the percentages of the number of
cells expressing PDGFRa mRNA out of the total number of cells from each subject in the ROI. While a
trend of an increased number of PDGFRa-expressing cells was observed in injured as compared to
sham when analyzing the whole width of the corpus callosum at around 1 and −3 mm from bregma,
this is not true when considering a smaller ROI of the corpus callosum at around 1 mm from bregma.
Moreover, such differences were at no timepoint statistically significant. * p indicates results from
one-way ANOVA analysis, while p is from Student t-test.
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3.4. Myelin Pathology: Anti-MBP and Anti-Rip Antibodies
Myelin changes following rotational TBI were investigated by means of anti-MBP antibody,
which recognizes the 21.5 kDa MBP isoform, and the anti-Rip antibody, which recognizes the 2,3 cyclic
nucleotide 3-phosphodiesterase in mature, myelinating oligodendrocytes and myelin sheaths.
In the corpus callosum, both MBP and Rip expression appeared inhomogeneous, but similar
between sham and injured animals at all timepoints, so that no clear difference between sham and
injured rats was observed (Figure 10).
However, when performing quantitative analysis of Rip expression as mean grey value of the
microscopy picture from each ROI bilaterally, this revealed changes in Rip expression (p≤ 0.05) between
sham and exposed animals at 24 h, both at the border of the CC with the caudoputamen and at the CC
“SVZ”, as well as at 7 d at the CC “SVZ” (Figure 11).
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Figure 10. Rip (top row) and MBP (bottom row) expression in the corpus callosum.
Fluorescence microscopy photographs of the corpus callosum (coronal sections) in different regions of
interest. MBP nd Rip stainings identify the myelin sheath. (A,F) The highlight d area refers to the
area represe ted in each row. (B–E) anti-Rip antibody expression in the corpus callosum at around
1 mm from bregma, adjacent to the lateral ventricle. Rip expression appears similar between sham
and exposed animals at all timepoints. (G–J) anti-MBP antibody expression in the corpus callosum at
around −3 mm from bregma. No clear difference is noted between sham and exposed animals at all
timepoints. Scale bar = 200 µm.
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Figure 11. Rip expression analysis. (A,B) Examples of Rip expression in the CC “SVZ” in the
sham and 24 h injured rat, respectively. The circle highlights an area of Rip expression, which is
perceived as brighter, reflecting higher mean grey values (16,000 in (B)) at the quantitative analysis.
Similarly, the rectangles highlight the area of the caudoputamen used as control for mean grey value,
which is higher (15,600 and 17,200 in (A) and (B), respectively) than in the sham CC (13,400 in (A)).
Scale bar = 200 µm. (C–E) The graphs represent quantitative analysis of Rip expression expressed as
mean grey values. The ROI for each graph is represented by the red highlighted area in the schematic
inserts. (C) Statistically significant (p ≤ 0.05) difference of Rip expression was found between sham and
injured animals at 24 h, as well as across injured animals, at the CC border with the caudoputamen.
(D) Statistically significant (p ≤ 0.05) difference in Rip expression was also found between sham and
injured animals at 24 h and 7 d, as well as across injured animals, at the CC “SVZ”. * p indicates results
from one-way ANOVA analysis, while p from Student t-test.
3.5. Neuronal Stress: Anti-HSP70 and Anti-ATF3 Antibodies
HSP70 and ATF3 were expressed, in most cases, focally in the right dorsal cortex, both in frontal
and in more caudal sections. An increased marker expression was also seen in the habenular nuclei and
at the border of the hippocampal dentate gyrus with the stria medullaris (Figure 12). In one case minor
HSP70 and ATF3 immunolabelling was noticed in the caudoputamen only. In one case, the cingulate
cortex, somatosensory cortex and the corpus callosum showed an increased expression of the markers
(Figure 13). The degree of neuronal stress—as indicated by HSP70 and ATF3 expression—seemed to
be decreased by 7 d, with their expression being strongest at 24–72 h. Sham animals were negative for
both HSP70 and ATF3. Only rare (ranging from zero to eight double positive neurons per 0.56 mm2)
neuron cell bodies expressing HSP70 and ATF3 also showed abundant APP fluorescence.
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to the area represented in each row. (B–E) HSP70 (red) and APP (green) double staining in the dorsal 
cortex. While APP expression remains elevated through 7d, HSP70 expression is comparatively 
decreased at 7 d. Few neurons are HSP70+/APP+. (G–J) ATF3 (red) and APP (green) double staining 
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Figure 12. HSP70/ATF3/APP expression reflecting neuronal stress. (A,F) The highlighted area refers to
the area represented in each row. (B–E) HSP70 (red) and APP (green) double staining in the dorsal
cortex. While APP expression remains elevated through 7 d, HSP70 expression is comparatively
decreased at 7 d. Few neurons are HSP70+/APP+. (G–J) ATF3 (red) and APP (green) double staining
in the habenular nuclei. ATF3 follows the same expression pattern as HSP70, with decreased marker
uptake at 7 d. In all cases, sham animals do not express any of the tested markers, with only the baseline
marker uptake visible. Scale bar = 150 µm (Scale bar = 100 µm in image (F)).
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Figure 13. HSP70/APP double-staining in 24 h trauma-exposed animals. (A,C) The highlighted area
refers to the area represented in the adjacent microphotograph. (B) HSP70 and APP expression in the
cingulate cortex. Few neurons are positive for both markers. (D) HSP70 and APP expression in the
caudoputamen, close to its interface with the corpus callosum. Scale bar = 200 µm.
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All the results—divided according to survival time and ROI—from investigations carried out in
this study are summarized in Table 4.
Table 4. Summary of results. Changes in Olig2 and PDGFRa are not statistically significant. + refers to
expression of the antibody at similar levels as the sham; - refers to no expression of the antibody,
similarly to sham; ↑ refers to increased expression of the antibody, as compared to sham; ↓ refers to
decreased expression of the antibody, as compared to sham; N.I. means that the ROI was not investigated
for that specific antibody. * changes observed in only one subject.
Survival
Time ROI APP MBP Rip OLIG2 A2B5 NG2 PDGFRa HSP70 ATF3
24 h
CC
“SVZ” ↑ + ↑ + + + + - -
CC
“BORDER” ↑ + ↑ + - + + ↑ * -
CC
“OCCIPITAL” ↑ + + ↓ - + ↑ ↑ * -
DORSAL
CORTEX ↑ N.I. N.I. N.I. N.I. N.I. N.I. ↑ ↑
HABENULAR
NUCLEI ↑ N.I. N.I. N.I. N.I. N.I. N.I. ↑ ↑
72 h
CC
“SVZ” ↑ + + + + + + - -
CC
“BORDER” ↑ + + ↓ - + ↓ - -
CC
“OCCIPITAL” ↑ + + ↓ + ↑ - -
DORSAL
CORTEX ↑ N.I. N.I. N.I. N.I. N.I. N.I. ↑ ↑
HABENULAR
NUCLEI ↑ N.I. N.I. N.I. N.I. N.I. N.I. ↑ ↑
7 d
CC
“SVZ” ↑ + ↑ + + + ↑ - -
CC
“BORDER” ↑ + + + - + ↓ - -
CC
“OCCIPITAL” ↑ + + ↓ - + ↑ - -
DORSAL
CORTEX ↑ N.I. N.I. N.I. N.I. N.I. N.I. ↑ ↑
HABENULAR
NUCLEI ↑ N.I. N.I. N.I. N.I. N.I. N.I. ↑ ↑
4. Discussion
The objective of this study was to assess, for given survival times, how myelin and cells
involved in its formation and degradation react to rotational brain injury. In particular, we assess
the presence and location of axonal injury through the detection of APP expression, oligodendrocyte
activity and distribution of their progenitor cells, through analysis of Olig2 (antibody and mRNA)
and A2B5, NG2 antibodies, PDGFRa mRNA respectively. We also aim at assessing the post-injury
myelination status by means of MBP and Rip expression and neuronal somata stress. This study
continues the work by Davidsson et al. [46] on the understanding of DAI ensuing from sagittal
angular acceleration trauma of the rat’s head. While qualitative analysis was performed through
visual analysis of immunohistochemistry slides for all selected markers, quantitative analysis was
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performed by image analysis of IHC slides for APP and Rip expression, and of RNAscope® slides
for Olig2 and PDGFRa expression with Fiji ImageJ. RNAscope® slides were chosen for quantitative
analysis of Olig2 and PDGFRa for their clear expression of the investigated mRNA and ease of analysis
through well-established protocols. These investigations were carried out by analyzing the specimen
at 24 h, 72 h and 7 d after rotational TBI, in different brain areas (corpus callosum, dorsal cortex,
habenular nuclei). The study was designed as such so as to insert the results (Table 4) within a specific
timeframe and to estimate areas that are more susceptible to injury depending on their location in the
frontal–caudal axis. The choice of such regions was based on their anatomical position with respect to
the center of rotation, as a gradient of increasing injury severity can be observed moving further away
from the skull base, in the frontal–caudal axis [5,49,50]. From a mechanical point of view, shear stress
significantly affects areas that are found between tissues with different elasticity and white matter
tracts that are oriented transversally to the plane of rotation [3,51,52]. This is of interest when trying to
determine the threshold for axonal injury, myelin degradation and oligodendrocyte loss, i.e., for similar
angular acceleration, different brain regions react differently, resulting in different degrees of injury.
4.1. Axonal Injury in TBI
Axonal injury is an important pathologic feature of TBI as it is associated clinically with
unconsciousness, cognitive deficits, and generally poor outcome [7]. The pathophysiology of axonal
injury is based on the mechanical damage to axons secondary to stretching and damage at a cellular
level, primarily involving altered homeostasis and an increased calcium inflow resulting in axonal
swelling and the accumulation of axonal transport proteins [4,53–55].
An APP antibody has been used as marker of axonal injury as it reflects the accumulation of the
fast transport APP in the injured section of an axon, hence it is able to detect early axonal injury [12]
and its pattern of expression (i.e., fusiform swellings, beaded and thick filaments), and distribution
is specific to traumatic injury [56]. Differently from what the authors had done in previous studies
investigating the same sagittal rotational acceleration model [46], APP immunostaining has been
performed on formalin-fixed tissues because of the improved results shown during preliminary marker
testing on both fresh and fixed tissues, especially when double stained with other markers (MBP, A2B5).
Quantitative and qualitative analysis of APP expression following rotational TBI confirmed what
was expected from the results of previous studies. Throughout the 24 h–7 d survival time window,
the analysis of APP expression in the frontal sections of the brain has shown APP-positive axon profiles
localized mostly at the interfaces between white and gray matter tracts. This finding is consistent
with the fact that the most susceptible areas to injury are those where there is a difference in tissue
elasticity [3,5], allowing for the sliding of one region over the other during rotational insult, thus causing
shear stress [4]. Instead, in the corpus callosum in the occipital units, APP expression revealed a
decreased (p ≤ 0.05) amount of axonal injury (16.9 ± 7.10 APP+ profile) as compared to the frontal
brain (37.6 ± 29.4 APP+ profiles).
This could be explained by the anatomical position: higher tissue shear stress and strain with
higher risk of damage to the brain tissue is thought to occur more frontally than occipitally [5].
It might also be due to the fact that the occipital corpus callosum has a lower axon density [57].
The pattern of axonal injury produced by the rotational model of injury used in this study is in line
with that produced by the rat finite-element model of rotation head trauma at similar levels of head
acceleration [58]. Interestingly, Li et al. show opposite findings, i.e., APP is expressed abundantly
primarily in the occipital corpus callosum, when investigating trauma produced by coronal rotation
and lateral translation of the rats’ heads [59]. On the other hand, the degree of APP expression over
time follows the same pattern as the one observed in this study: a decrease in APP expression by
7 d, after peaking at 24 h post-injury. This is a well-known pattern [59–62] and seems to occur due to
increased concentrations of APP degrading enzymes within the injured axons, such as caspase-3 [63–65],
as well as the recovery of mildly injured axons [66].
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While the study included three older, heavier subjects (691.7 ± 56 g versus 409.4 ± 48.2 g), this did
not significantly affect the degree of axonal injury resulting from the trauma, similarly to what was
previously described for the same model of injury [67] (unpublished), and to eliminate potential
biases due to weight differences, these three subjects were not included in the quantitative analysis,
rather only in the preliminary qualitative analysis.
4.2. Oligodendrocyte Loss
Having confirmed that this rotational model of TBI induces diffuse axonal injury (DAI),
we investigated the oligodendrocyte population to assess how they react to rotational TBI and
whether they are robust enough to survive this type of relatively mild, diffuse injury.
The presence of oligodendrocyte lineage cells in the regions of interest was studied through the
anti-Olig2 antibody and mRNA expression. Olig2 is a transcription factor restricted to oligodendrocyte
lineage and it is expressed early during development [35]. While Olig2 mRNA appeared to be less
abundant and a trend of lower number of Olig2-expressing cells was noted in the trauma-exposed
group as compared to the sham group, as well as from 24 h to 7 d survival times, Student t-test
and one-way ANOVA test revealed these changes to be not statistically significant. This might
be explained by the fact that the injury induced in this TBI model is not severe enough to cause
oligodendrocyte loss or that the initial proliferation of OPCs is occurring, so that both non-mature
and mature Olig2+ cells have been counted, offsetting the overall change in number of Olig2+ cells
between TBI-exposed and sham animals [34]. In future studies, other techniques to better detect Olig2+
cell loss should be used, such as a different oligodendrocyte marker (e.g., CC1) and/or markers for
apoptosis (e.g., caspase-3, TUNEL). Oligodendrocyte death following TBI is a known phenomenon,
observed early following injury, between 12 h and 7 d for fluid percussion models [68,69], and in
human studies [70]. Oligodendrocytes are vulnerable cells, sensitive to excitotoxicity (secondary to
glutamate and other excitatory neurotransmitters release in DAI) and to oxidative stress (as, to sustain
myelination process, they have high metabolic rates and consume high levels of ATP, but only have
scarce concentration of glutathione), as well as to inflammatory cytokines, all conditions present in
TBI [39,71].
4.3. Myelin Injury
The loss of oligodendrocytes leads to myelin damage and demyelination, leaving unmyelinated
axons prone to injury and affecting the information processing speed [32,72], making the demyelination
of intact axons possible [41]. Thus, enhancing oligodendrocyte survival and remyelination may offer
ways of reducing post-TBI morbidity.
Staining brain tissue with MBP antibodies has been widely used to study trauma-induced
demyelination [21,73]; MBP expression is decreased when the myelin is damaged.
This study indicated no decreased MBP expression as compared to baseline levels in sham.
Such findings could fit with the hypothesis that myelin damage is more likely to be a hallmark of
more severe TBI [25,33], as opposed to the milder TBI that is produced by the model used in this
study. Moreover, the absence of MBP decreased expression and demyelination fits, with no significant
oligodendrocyte loss found in the current study. Other authors report MBP expression is decreased
following severe TBI in focal injury model: Liu et al. [21] claim that MBP is degraded ipsilaterally in
the cortex and hippocampus between 2 and 72 h after controlled cortical impact (CCI). Ottens et al. [22]
have also found, at 48 h after CCI injury, decreased expression of the same MBP isoforms as tested in
this study. Yet, most authors have found evidence of demyelination starting at least 72 h, but more
commonly up to 7 d, after CCI [25,41,74,75]. Wu et al.’s [60] finding of myelin sheath disruption—seen at
electron microscopy—at 24 h in a model that combines angular and linear head acceleration. However,
in the present study, no evidence of decrease in MBP expression is observed by 7 d.
Further investigations were conducted with anti-Rip as an alternative to MBP. Rip recognizes the
CNP (2,3 cyclic nucleotide 3-phosphodiesterase) in mature, myelinating oligodendrocytes and stains
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the soma, cytoplasmic processes of oligodendrocytes and myelin sheaths—similarly to MBP [76,77].
Although by visual inspection Rip was expressed in a non-homogeneous fashion in the regions of
interest both in sham and injured animals at any survival time, quantitative analysis (using mean
grey value as parameter) revealed statistically significant (p ≤ 0.05) differences in Rip expression
between sham and injured animals already at 24 h at the interface between CC and caudoputamen,
and also at 7 d in the CC “SVZ”. This is in contrast to what other authors report, as decreased
Rip expression was observed only by 7 d in a fluid percussion model of TBI [33]. Moreover, these
results are confounding, as the mean grey value analysis shows higher values for the injured animals,
while for demyelinating areas the authors expected to find decreased expression of Rip, which should
have appeared darker, and thus mean grey values should have appeared lower. This hypothesis
was supported by the results of other authors investigating Rip expression following TBI in areas
such as fimbriae and external capsule [33]. A possible explanation for these results might be that
when myelin is intact, Rip expression is strong and uniform, however, in a densely myelinated area
such as the CC, this appears as background-like staining, which is reflected by low mean grey values.
On the other hand, if—following injury—myelin is not compacted anymore, a decreased expression
of Rip creates a visual contrast with its surrounding, so that the image appears brighter (Figure 11B)
and it is translated into higher mean grey values. To test this hypothesis, mean grey value was
calculated on the less densely myelinated caudoputamen, and this resulted in higher mean grey
values than those found in the corpus callosum (MGV average in caudoputamen and CC of randomly
chosen subjects of 15,283 and 13,653, respectively). These results seem to confirm that, in this study,
areas of decreased Rip expression in injured animals—possibly corresponding to areas of myelin
decompaction—are represented by higher mean grey values.
Nonetheless, further studies looking at myelin through electron microscopy would be needed to
confidently assess the presence of demyelination in this model of injury.
4.4. TBI-Induced OPCs Reaction
The loss of mature oligodendrocytes and demyelination are major triggers for OPC activation
and proliferation [36,78,79]. Immature glial precursor cells have been detected by staining with A2B5
marker [80,81]. An abundant presence of A2B5+ cells in sham groups and rotational TBI-exposed
groups was observed in the subventricular zone (SVZ) at all investigated survival times. This finding
may be explained by the fact that neural stem cells are maintained in the SVZ of the adult brain [82–84],
while in basal conditions they lack the ability to give rise to glial cells during adulthood, myelin damage
seems to be a stimulus for these glial precursor cells to proliferate, migrate in the injury area and
differentiate in glial cells, contributing to myelin repair [85]. SVZ-derived progenitors (A2B5+ cells),
together with parenchymal OPCs (NG2+ cells), are the main sources of oligodendrocyte progenitor
cells in the adult brain [85,86]. The proliferation of SVZ-derived progenitor cells has been described as
early as 48 h, with a peak at two weeks after direct demyelinating insult produced by focal TBI [87].
However, in this study we do not report evidence of A2B5+ cells proliferation up to 7 d. Similarly,
Sullivan et al. [25] did not find the proliferation of SVZ progenitor cells up to 7 d post-TBI. In future
studies, it might be worth investigating later timepoints to assess whether A2B5+ cell proliferation
occurs—possibly in a delayed fashion—for the rotational TBI model used. For example, Chen et al. [61]
found increasing numbers of SVZ precursor cells from six months after TBI, while Menn et al. [86]
found a subset of these cells to be differentiated in mature oligodendrocytes and scattered through
the corpus callosum and striatum at 21 days post-injury. Given the scarce amount of A2B5+ cells
at all timepoints and regions of interest—except for at the SVZ—for all angular acceleration levels,
attempts at correlating the presence of immature glial precursor cells with axonal injury have not
produced any results.
Oligodendrocyte-restricted precursor cells were studied with an anti-NG2 antibody and PDGFRa
mRNA. NG2 is a chondroitin sulfate expressed by OPCs [44,88]. However, it also stains pericytes,
thus making it necessary to co-label it with Occludin, a tight-junction protein, to confidently distinguish
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the two NG2+ cells. While NG2 is commonly used as marker of OPCs, it is also expressed by
glial cells differentiating into neurons or astrocytes, as well as macrophages [40,70,89–92]. For this
reason, the analysis of NG2 immunostaining was only qualitative, supported by cell morphology
observed at high magnification, while quantitative OPC analysis was based on PDGFRa mRNA.
PDGFRa—platelet-derived growth factor receptor alpha—is a widely used marker for oligodendrocyte
precursor cells in the central nervous system, as its expression—which occurs at about the same
time as NG2—marks the OPC fate of the cell [70,93,94]. NG2+ OPCs were observed in all regions
of interest and timepoints, at similar levels between TBI and sham animals, with no difference for
increasing levels of angular head acceleration. Following oligodendrocyte death and demyelination,
resident oligodendrocyte progenitor cells are activated and can proliferate, migrate and differentiate
into mature oligodendrocytes, allowing for potential repair post-injury [37,39,95]. Thus, a thorough
understanding of the mechanisms regulating oligodendrocyte death and OPCs activation is important
to find therapeutic strategies to promote and improve recovery after TBI. Wide variability characterizes
the phenomenon of OPC proliferation, as confirmed by the different results in different studies,
using different models of TBI. Our rotational TBI study does not report and increased number of OPCs
by 7 d. Instead, a marked increased number of NG2+ OPCs was found by other authors at the corpus
callosum between 24 h and 7 d after CCI [25,96], while increasing number of OPCs were seen from
72 h to 7 d after fluid percussion TBI at the corpus callosum [25,40].
Considering that most authors report an increased number of NG2+ OPCs around 7 d post-TBI at
the corpus callosum, the injury induced by our model of rotational TBI might not be severe enough to
produce marked changes in OPC number. Moreover, the lack of OPC proliferation is to be expected in
relation to the lack of oligodendrocyte loss and demyelination observed in the current study. In future
studies, it might be of interest to look into the growth factors and cytokines (e.g., FGF2, TGFb) that
regulate OPCs’ activation and proliferation [38], to know whether the cellular machinery is activated
at all, and, if so, if evidence of an increased number of OPCs can be detected at later survival times.
4.5. Neuronal Somata Stress
Diffuse axonal injury, as marked by APP expression, is thought to induce, at least transiently,
neuronal cell body stress and damage [14]. Considering that our model of rotational TBI induces
axonal injury mostly at the corpus callosum, in particular at the interface with the lateral ventricles and
caudoputamen, we investigated the dorsal cortex for neuronal stress by means of HSP70 and ATF3,
together with APP marker. HSP70 is part of the heat shock family, and it is strongly upregulated by a
variety of stress stimuli (trauma, ischemia, heat, hypoxia), peaking at 24 h after exposure [16,18,19].
Similarly, ATF3 (activating transcription factor 3) is used as a cellular stress marker given its association
with several pathways involved in cellular stress response [97,98]. Moreover, its induction has been
well described in neurons, as well as in immune cells during neuroinflammatory processes, and occurs
soon after the insult [99].
In six out of nine TBI-exposed animals (from the qualitative and quantitative analysis group),
we found a focal area of injury superficially in the right dorsal cortex, in which neurons expressed
HSP70, ATF3 and APP, in both frontal (about 1–1.3 mm bregma) and more caudal (about −3 mm
bregma) brain sections. HSP70 and ATF3 expression was strongest at 24 h, but still moderate by 7 d.
Other authors report expression of HSP70 and ATF3 up to 72 h following FP and CCI, and more
extensively through the hippocampus, motor and somatosensory cortices [14,19]. The finding of focal
injury is in contrast with the diffuse TBI typically produced by our model of injury, in which no such
injury had been previously described [46,100]. Interestingly, Singleton et al. [14] did not find any
HSP70 expression in the cortical area directly underlying the site of focal impact. The expression of
HSP70/ATF3 and APP in deep structures such as the habenular nuclei and stria medullaris, the interface
with the dentate gyrus of the hippocampus, indicates a possible multifactorial nature of neuronal cell
body stress in the investigated rotational TBI model, which could be caused, to some extent, directly
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by axonal injury in the context of head angular acceleration, as well as neuroinflammation and axonal
injury-mediated neuronal stress, and other secondary mechanisms, such as hypoxia [16,99].
5. Conclusions
This work gives an insight into white matter pathology following diffuse TBI induced by angular
acceleration of the rat head. Diffuse APP expression—which was maximal at the white–gray matter
border and greater in the frontal than the occipital regions throughout the 24–72 h time window
and decreasing by 7 d—indicates that the rotational TBI model used in this study produces DAI for
any angular acceleration between 0.96 and 2.2 Mrad/s2. While we detected moderate axonal injury,
as indicated by stable expression of APP, and increased expression of neuronal stress markers, we found
only minor trends of decreased oligodendrocyte lineage cell number and OPC proliferation, and mostly
conserved myelination, as was visible through MBP and Rip immunostaining. This might indicate
that the oligodendrocyte population could be robust enough to withstand the trauma ensuing from
the delivered angular head acceleration. All in all, this confirms the mild severity of the investigated
rotational TBI model.
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